Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

Completed · Phase 2

Conditions studied: Carpal Tunnel Syndrome

In brief

The purpose of the study is to explore the potential usefulness of Synera for the treatment of pain associated with mild to moderate carpal tunnel syndrome.

Key facts

Study ID

NCT00991068

Run by

ZARS Pharma Inc.

People needed

24

Starts

2009-09-01

Expected to finish

2010-03-01

Last updated by the study team

2012-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pain associated with mild to moderate carpal tunnel syndrome in a single wrist
• Have recent (within 3 months) electrodiagnostic evidence of carpal tunnel syndrome (CTS)

You may not qualify if…

• Have bilateral carpal tunnel syndrome
• Have another peripheral neuropathy in the affected limb
• Have had an injection into the carpal tunnel within 8 weeks
• Have had surgical release of the target wrist within previous 6 months
• Have electrodiagnostic evidence of severe CTS
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• International Clinical Research Institute — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.